• Akhavan, S., De Cristofaro, R., Peyvandi, F., Lavoretano, S., Landolfi, R. & Mannucci, P.M. (2002) Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood, 100, 13471353.
  • Akhavan, S., Miteva, M.A., Villoutreix, B.O., Venisse, L., Peyvandi, F., Mannucci, P.M., Guillin, M.C. & Bezeaud, A. (2005) A critical role for Gly25 in the B chain of human thrombin. Journal of Thrombosis and Haemostasis, 3, 139145.
  • Bezeaud, A., Elion, J. & Guillin, M.C. (1988) Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant. Blood, 71, 556561.
  • Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S.R. & Hofsteenge, J. (1989) The refined 1.9 Å crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO Journal, 8, 34673475.
  • Dang, O.D., Vindigni, A. & Di Cera, E. (1995) An allosteric switch controls the procoagulant and anticoagulant activities of thrombin. Proceedings of the National Academy of Sciences of the United States of America, 92, 59775981.
  • Degen, S.J. & Davie, E.W. (1987) Nucleotide sequence of the gene for human prothrombin. Biochemistry, 26, 61656177.
  • Degen, S.J., McDowell, S.A., Sparks, L.M. & Scharrer, I. (1995) Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala. Thrombosis and Haemostasis, 73, 203209.
  • Henriksen, R.A., Dunham, C.K., Miller, L.D., Casey, J.T., Menke, J.B., Knupp, C.L. & Usala, S.J. (1998) Prothrombin Greenville, Arg517[RIGHTWARDS ARROW]Gln, identified in an individual heterozygous for dysprothrombinemia. Blood, 91, 20262031.
  • Huntington, J.A. & Esmon, C.T. (2003) The molecular basis of thrombin allostery revealed by a 1.8 Å structure of the ‘‘slow’’ form. Structure, 11, 469479.
  • Miyata, T., Aruga, R., Umeyama, H., Bezeaud, A., Guillin, M.C. & Iwanaga, S. (1992) Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. Biochemistry, 31, 74577462.
  • Pineda, A.O., Carrell, C.J., Bush, L.A., Prasad, S., Caccia, S., Chen, Z.W., Mathews, F.S. & Di Cera, E. (2004) Molecular dissection of Na+ binding to thrombin. Journal of Biological Chemistry, 279, 3184231853.
  • Sun, W.Y., Smirnow, D., Jenkins, M.L. & Degen, S.J. (2001) Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia. Thrombosis and Haemostasis, 85, 651654.